Each newborn of England will be mapped to assess the risk of hundreds of diseases under NHS schemes for the next 10 years.

The scheme reported for the first time by The Daily Telegraph is part of a government drive towards predicting and preventing the disease, which will also see £ 650M investment in DNA Research for all patients by 2030.

Health Secretary Wes Streeting stated that gene technology will “enable healthcare to have a leapphog disease, so we are in front of it rather than reacting to it”.

It comes after a study analyzing the genetic code of 100,000 infants in October.

The government’s 10 -year plan for NHS, which is going to appear in the next few weeks, aims to reduce the pressure on services.

The Department of Health and Social Care stated that genomics – gene studies – and AI will be used to “revolution in prevention” and provide rapid diagnosis and “initial warning signal for disease”.

Screening of newborns for rare diseases will include sequencing of its complete DNA using blood samples from their umbilical cord.

There are about 7,000 single gene disorders. The NHS study that began in October, only looks for gene disorders that develop in childhood and for which effective treatments occur.

Currently, newborns are given only a heelpro -blood test that examines nine serious conditions, including cystic fibrosis.

The Health Secretary said in a statement: “With the power of this new technology, patients will be able to achieve personal healthcare to prevent sick health before the beginning of symptoms, helping people live a healthy life, to help people stay for a long time.